Technological Advancements in the Cath Lab – By Sarah Ertley

Posted on by Aviva Clayman

Member Article

Is your hospital keeping pace with the rapid evolution of medical technology? In high-acuity environments such as the cardiac catheterization laboratory, advancements in equipment and communication systems are not merely conveniences—they are critical drivers of efficiency, precision, and patient outcomes. From my experience working across eight different hospitals during clinical and professional rotations, the impact of up-to-date technology on workflow and case management is both immediate and measurable.

Continue reading Technological Advancements in the Cath Lab – By Sarah Ertley

Career ladders getting higher for nurses—what about allied health?

Posted on by Kurt Jensen

All cardiac care professionals could see more professional development, opportunity.

With the switch to value-based medicine, more nurses are becoming hospital CEOs reads an article published online today in Hospitals & Health Networks Magazine.

Three hospitals in the six-hospital Memorial Healthcare System in Florida are now run by nurses—for RNs, it seems, the career ladder has grown longer, with more nurses climbing higher in healthcare management.

Beyond Florida, an August 2016 article in Becker's Hospital Review listed 33 nurses who transitioned to hospital CEOs.

Why are more hospitals tapping nurses to run the organization? Management competencies are changing, says Lamont Yoder, RN, of the American Organization of Nurse Executives to H&HN Magazine's Maggie Van Dyke.

Continue reading Career ladders getting higher for nurses—what about allied health?

AACC scientists identify new cardiac biomarker

Posted on by Kurt Jensen

Plus, get ready for high sensitivity cardiac Troponin assays in practice.

Laboratory medicine experts discovered a new lipid biomarker panel to detect heart failure with reduced ejection fraction (HFrEF) even before symptoms present, with "much greater certainty than standard tests for this condition," according to a January 5 press release from the American Association for Clinical Chemistry (AACC).

The January issue of the AACC's journal, Clinical Chemistry focuses on cardiovascular disease and features research reflecting a "growing understanding of the molecular signatures of heart disease," according to the press release, and a trend towards developing "more precise tests for the early diagnosis, monitoring, and targeted treatment."

The study in question identified three new cardiac lipid biomarkers, a cardiac lipid panel (CLP), which "significantly improved diagnostic performance" when combined with the current standard biomarker approach for diagnosing heart failure, NT-proBNP.

Continue reading AACC scientists identify new cardiac biomarker

Two common ways you might misinterpret medical research

Posted on by Kurt Jensen

Sophisticated statistics in medical research can be hard to translate to layman's terms, and when they are, these common misinterpretations can be downright misleading.

1. Odds ratios don't express relative risk.

In 1999, media reports resulting from a study published in the New England Journal of Medicine wrongly suggested that black patients and women were 40 percent less likely than white patients and men, respectively, to undergo cardiac catheterization.

The study's authors had used odds ratios to describe the significance of their findings—a common practice among statistically sophisticated researchers—which showed that black patients and women were definitely less likely to be referred for invasive procedures than white patients and men, but not how much less likely.

Continue reading Two common ways you might misinterpret medical research